AKT1, a core serine/threonine kinase within the PI3K/AKT pathway, is inhibited by CHR via the PI3K/AKT/mTOR axis, as evidenced by reduced AKT expression and ameliorated neuropathology in a propionic acid-induced rat autism model (Sharma et al., 2022). Here, MARK2 is linked to autism.